Non-Alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-Alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient s risk of advanced and progressive liver disease. In this perspective different imaging techniques have been developed in last decades and showed high performance in liver fibrosis evaluation. Strengths and weaknesses of all imaging methods are summarized in this review. (Cite this article as: Liguori A, Ainora ME, Riccardi L, De Matthaeis N, Pizzolante F, Gasbarrini A, et al. The role of elastography in non-Alcoholic fatty liver disease. Minerva Gastroenterol.

Liguori, A., Ainora, M. E., Riccardi, L., Dematthaeis, N., Pizzolante, F., Gasbarrini, A., Zocco, M. A., Grieco, A., Rapaccini, G., Miele, L., The role of elastography in non-Alcoholic fatty liver disease, <<MINERVA GASTROENTEROLOGY>>, n/a; 67 (2): 164-170. [doi:10.23736/S2724-5985.21.02801-4] [http://hdl.handle.net/10807/203794]

The role of elastography in non-Alcoholic fatty liver disease

Liguori, A.;Ainora, M. E.;Riccardi, L.;Pizzolante, F.;Gasbarrini, A.;Zocco, M. A.;Grieco, A.;Rapaccini, G.;Miele, L.
2021

Abstract

Non-Alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-Alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient s risk of advanced and progressive liver disease. In this perspective different imaging techniques have been developed in last decades and showed high performance in liver fibrosis evaluation. Strengths and weaknesses of all imaging methods are summarized in this review. (Cite this article as: Liguori A, Ainora ME, Riccardi L, De Matthaeis N, Pizzolante F, Gasbarrini A, et al. The role of elastography in non-Alcoholic fatty liver disease. Minerva Gastroenterol.
Inglese
Liguori, A., Ainora, M. E., Riccardi, L., Dematthaeis, N., Pizzolante, F., Gasbarrini, A., Zocco, M. A., Grieco, A., Rapaccini, G., Miele, L., The role of elastography in non-Alcoholic fatty liver disease, <<MINERVA GASTROENTEROLOGY>>, n/a; 67 (2): 164-170. [doi:10.23736/S2724-5985.21.02801-4] [http://hdl.handle.net/10807/203794]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/203794
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact